NuvoMed logo

NuvoMed Funding & Investors

NuvoMed offers a patented, disposable device called the DisImpactorTM, developed for the safe, fast, and effective relief of fecal impaction with maximum comfort and clinical efficacy. The company is committed to improving this unpleasant procedure for both the patient and physician. By significantly reducing the pain for the patient while providing a more capable tool for the physician, NuvoMed intends to provide the ultimate solution. The company was founded in 2012 and is based in Seattle, Washington.

nuvomed.com

Total Amount Raised: $1,425,653

NuvoMed Funding Rounds

  • Seed

    $390,637

  • Series A

    $500,000

    Series A Investors

    Keiretsu Forum Northwest
    Insite Partners
  • Series Unknown

    $535,016

Funding info provided by Diffbot.